Looksmax - Men's Self Improvement Forum
Welcome to the ultimate men’s self-improvement community where like-minded individuals come together to level up every aspect of their lives. Whether it’s building confidence, improving your mindset, optimizing health, or mastering aesthetics, this is the place to become the best version of yourself. Join the hood and start your transformation today.

Looksmax Oxytocin — an underrated regulator of bone metabolism | effects on osteoblasts, osteoclasts, and chondrocytes.

(2 Viewers)
Looksmax Oxytocin — an underrated regulator of bone metabolism | effects on osteoblasts, osteoclasts, and chondrocytes.
Joined
Nov 19, 2026
Posts
5
Reputation
24
Oxytocin is a peptide hormone that is synthesized primarily in the hypothalamus and released into the blood through the posterior pituitary gland. But it affects not only mental state, it also plays a significant role in bone metabolism.
In bone, it works through the OXTR receptor, which is located on osteoblasts and their precursors. Activation of these receptors can influence osteoblast differentiation and the activity of signaling pathways that affect bone mass.

EFFECTS ON OSTEOBLASTS AND BONE METABOLISM MARKERS
Oxytocin can stimulate osteogenic differentiation of cells.
BMP2 — a protein involved in the regulation of osteogenic differentiation.
RUNX2 — one of the key transcription factors required for osteoblast formation.
SP7 — a transcription factor required for further osteoblast differentiation.
ATF4 — a transcription factor involved in the functioning and maturation of osteoblasts.
ALP — a marker of osteoblastic activity associated with matrix mineralization.
OC — a protein involved in bone formation.
OPN and BSP — extracellular matrix proteins involved in mineralization and bone creation.
SHN2 and SHN3 — regulatory proteins involved in signal transduction and control of the expression of genes related to osteogenesis.
OT → OXTR → BMP-2 → SHN2/SHN3, SP7 and ATF4 → osteoblastic differentiation. RUNX2 is also among the regulators whose expression is increased by oxytocin.

Oxytocin stimulates the differentiation of osteoblasts into a mineralizing phenotype, which is accompanied by increased BMP2 expression. Then BMP2 acts on the intracellular BMP receptor system and the associated regulatory mechanisms. Key points:
BMPR1A, ALK3, BMPR1B, and ALK6 — type 1 BMP receptors.
BMPR2 — type 2 BMP receptor.
SMAD1, SMAD5, and SMAD9 — intracellular proteins responsible for signal transduction.
SMAD4 — a protein involved in forming the transcription complex..
Receptor activation leads to the phosphorylation of SMAD1/5/9, their interaction with SMAD4, and a subsequent effect on gene expression.
EFFECTS ON MESENCHYMAL STEM CELLS
Bone marrow mesenchymal stem cells are capable of differentiating into several cell types.
1. Osteoblasts
2. Chondrocytes
3. Adipocytes
Oxytocin can influence the direction of this differentiation by promoting osteogenesis and altering the balance between osteoblast and adipocyte formation. BMP2, RUNX2, SP7, and PPARG are involved in this. Increased activity of osteogenic factors and changes in adipogenic differentiation can shift the cellular balance toward bone tissue formation.
REGULATION OF BONE MATRIX MINERALIZATION
Oxytocin affects not only the differentiation of osteoblasts but also indicators of their functional activity. An increase in the expression of these markers has been observed:
ALP — alkaline phosphatase, involved in creating conditions for matrix mineralization.
BGLAP — the osteocalcin gene, a bone matrix protein.
SPP1 — the osteopontin gene, involved in the regulation of mineralization and cell-matrix interaction.
IBSP — the bone sialoprotein gene, involved in mineralization.
COL1A1 — the type 1 collagen gene, the main component of bone matrix.
These proteins ensure the formation of the extracellular matrix, as well as its subsequent mineralization. There is also a possible effect of oxytocin on the translocation of OXTR into the osteoblast nucleus and the regulation of their mineralizing activity.
EFFECTS ON OSTEOCLASTOGENESIS
Oxytocin also affects osteoclasts. The RANKL/RANK/OPG axis is involved here.
RANKL — a protein that binds to the RANK receptor and stimulates osteoclast differentiation.
RANK — a receptor located on osteoclasts.
OPG — a receptor that prevents RANKL from binding to RANK.
MCSF — a factor necessary for the survival and development of osteoclast precursors.
When RANKL binds to RANK, intracellular signaling is initiated involving TRAF6. After that, the following cascade is activated: RANKL -> RANK -> TRAF6 -> NF and MAPK -> cFOS -> NFATc1 -> osteoclastogenesis.
Oxytocin can increase RANKL and decrease OPG, thereby increasing the activity of osteoclast maturation. But the effect of oxytocin on mature osteoclasts differs from its effect on their precursors.
SUPPRESSION OF RESORPTIVE ACTIVITY OF MATURE OSTEOCLASTS
On one hand, it can stimulate the formation of osteoclasts, and on the other, it can suppress the resorptive activity of already mature osteoclasts. When OXTR is stimulated in mature osteoclasts, intracellular calcium increases. Unlike the short-term calcium signal produced by osteoblasts, in osteoclasts the calcium increase can be more prolonged. This promotes the formation of nitric oxide, which is involved in suppressing the functional activity of osteoclasts.
OT -> OXTR -> PLCB -> IP3 -> increase in intracellular calcium -> nitric oxide -> decrease in resorptive activity.
Oxytocin can suppress bone resorption by mature osteoclasts despite stimulating their formation. The number of osteoclasts ≠ the intensity of resorption.
ESTROGEN AND THE LOCAL OXYTOCIN/OXTR FEEDBACK LOOP
Estradiol can stimulate the synthesis of oxytocin by osteoblasts via MAPK/ERK, as well as influence OXTR expression. Ultimately, a local positive feedback loop is formed: estradiol -> MAPK/ERK -> increased oxytocin synthesis and OXTR expression -> enhanced oxytocin/OXTR signaling. Osteoblasts themselves are capable of synthesizing oxytocin, acting on their own receptors and on neighboring cells. Bone can use not only oxytocin coming from the bloodstream but also the local oxytocin system.
INTERACTION WITH OTHER SIGNALING PATHWAYS
MAPK/ERK — involved in signal transduction from OXTR and regulation of osteoblast activity.
BMP/SMAD — regulates osteogenic differentiation.
RANKL/RANK/OPG — controls the formation and activity of osteoclasts.
PGE2 — a local mediator involved in the regulation of bone remodeling.
Leptin and adiponectin — adipokines that link energy metabolism to the state of bone tissue.
AVP — a neuropeptide that has structural and functional similarity to oxytocin and is involved in the regulation of a number of physiological processes.
There is also a connection with Wnt, but it's not as clear-cut there.
OXYTOCIN AND CHONDROCYTES
OXTR is expressed in chondrocytes, and it can influence the expression of:
SOX9 — a key transcription factor of chondrogenic differentiation.
COMP — an extracellular matrix protein of cartilage.
SOX9 is especially important for the formation and maintenance of chondrocytes, primarily in the proliferative zone. It regulates the expression of a number of cartilage matrix genes: type 2 collagen and ACAN. The detection of an effect on SOX9 and COMP does not yet prove that oxytocin stimulates chondrocyte proliferation or hypertrophy. This is only a theory.
EFFECT OF OXYTOCIN ON BONE MINERAL DENSITY
Many studies have demonstrated a significant association between oxytocin and BMD, but not everything is so clear-cut. For example, in a study involving 1,097 postmenopausal women, higher oxytocin values were associated with BMD levels. In men aged 50+, no association was found between oxytocin and BMD. In men with diabetes insipidus, an association was found between oxytocin and BMD. There is an association, but it's not as clear-cut as one would like.
CONCLUSION
As it turns out, oxytocin is not just a hormone that affects mood and trust. It has a full-fledged effect on bone, as well as a theoretical effect on growth plates.

 

irapeadmins

#Caradelevingne
Joined
Aug 12, 2026
Posts
2,504
Reputation
6,136
Oxytocin is a peptide hormone that is synthesized primarily in the hypothalamus and released into the blood through the posterior pituitary gland. But it affects not only mental state, it also plays a significant role in bone metabolism.
In bone, it works through the OXTR receptor, which is located on osteoblasts and their precursors. Activation of these receptors can influence osteoblast differentiation and the activity of signaling pathways that affect bone mass.

EFFECTS ON OSTEOBLASTS AND BONE METABOLISM MARKERS
Oxytocin can stimulate osteogenic differentiation of cells.
BMP2 — a protein involved in the regulation of osteogenic differentiation.
RUNX2 — one of the key transcription factors required for osteoblast formation.
SP7 — a transcription factor required for further osteoblast differentiation.
ATF4 — a transcription factor involved in the functioning and maturation of osteoblasts.
ALP — a marker of osteoblastic activity associated with matrix mineralization.
OC — a protein involved in bone formation.
OPN and BSP — extracellular matrix proteins involved in mineralization and bone creation.
SHN2 and SHN3 — regulatory proteins involved in signal transduction and control of the expression of genes related to osteogenesis.
OT → OXTR → BMP-2 → SHN2/SHN3, SP7 and ATF4 → osteoblastic differentiation. RUNX2 is also among the regulators whose expression is increased by oxytocin.

Oxytocin stimulates the differentiation of osteoblasts into a mineralizing phenotype, which is accompanied by increased BMP2 expression. Then BMP2 acts on the intracellular BMP receptor system and the associated regulatory mechanisms. Key points:
BMPR1A, ALK3, BMPR1B, and ALK6 — type 1 BMP receptors.
BMPR2 — type 2 BMP receptor.
SMAD1, SMAD5, and SMAD9 — intracellular proteins responsible for signal transduction.
SMAD4 — a protein involved in forming the transcription complex..
Receptor activation leads to the phosphorylation of SMAD1/5/9, their interaction with SMAD4, and a subsequent effect on gene expression.
EFFECTS ON MESENCHYMAL STEM CELLS
Bone marrow mesenchymal stem cells are capable of differentiating into several cell types.
1. Osteoblasts
2. Chondrocytes
3. Adipocytes
Oxytocin can influence the direction of this differentiation by promoting osteogenesis and altering the balance between osteoblast and adipocyte formation. BMP2, RUNX2, SP7, and PPARG are involved in this. Increased activity of osteogenic factors and changes in adipogenic differentiation can shift the cellular balance toward bone tissue formation.
REGULATION OF BONE MATRIX MINERALIZATION
Oxytocin affects not only the differentiation of osteoblasts but also indicators of their functional activity. An increase in the expression of these markers has been observed:
ALP — alkaline phosphatase, involved in creating conditions for matrix mineralization.
BGLAP — the osteocalcin gene, a bone matrix protein.
SPP1 — the osteopontin gene, involved in the regulation of mineralization and cell-matrix interaction.
IBSP — the bone sialoprotein gene, involved in mineralization.
COL1A1 — the type 1 collagen gene, the main component of bone matrix.
These proteins ensure the formation of the extracellular matrix, as well as its subsequent mineralization. There is also a possible effect of oxytocin on the translocation of OXTR into the osteoblast nucleus and the regulation of their mineralizing activity.
EFFECTS ON OSTEOCLASTOGENESIS
Oxytocin also affects osteoclasts. The RANKL/RANK/OPG axis is involved here.
RANKL — a protein that binds to the RANK receptor and stimulates osteoclast differentiation.
RANK — a receptor located on osteoclasts.
OPG — a receptor that prevents RANKL from binding to RANK.
MCSF — a factor necessary for the survival and development of osteoclast precursors.
When RANKL binds to RANK, intracellular signaling is initiated involving TRAF6. After that, the following cascade is activated: RANKL -> RANK -> TRAF6 -> NF and MAPK -> cFOS -> NFATc1 -> osteoclastogenesis.
Oxytocin can increase RANKL and decrease OPG, thereby increasing the activity of osteoclast maturation. But the effect of oxytocin on mature osteoclasts differs from its effect on their precursors.
SUPPRESSION OF RESORPTIVE ACTIVITY OF MATURE OSTEOCLASTS
On one hand, it can stimulate the formation of osteoclasts, and on the other, it can suppress the resorptive activity of already mature osteoclasts. When OXTR is stimulated in mature osteoclasts, intracellular calcium increases. Unlike the short-term calcium signal produced by osteoblasts, in osteoclasts the calcium increase can be more prolonged. This promotes the formation of nitric oxide, which is involved in suppressing the functional activity of osteoclasts.
OT -> OXTR -> PLCB -> IP3 -> increase in intracellular calcium -> nitric oxide -> decrease in resorptive activity.
Oxytocin can suppress bone resorption by mature osteoclasts despite stimulating their formation. The number of osteoclasts ≠ the intensity of resorption.
ESTROGEN AND THE LOCAL OXYTOCIN/OXTR FEEDBACK LOOP
Estradiol can stimulate the synthesis of oxytocin by osteoblasts via MAPK/ERK, as well as influence OXTR expression. Ultimately, a local positive feedback loop is formed: estradiol -> MAPK/ERK -> increased oxytocin synthesis and OXTR expression -> enhanced oxytocin/OXTR signaling. Osteoblasts themselves are capable of synthesizing oxytocin, acting on their own receptors and on neighboring cells. Bone can use not only oxytocin coming from the bloodstream but also the local oxytocin system.
INTERACTION WITH OTHER SIGNALING PATHWAYS
MAPK/ERK — involved in signal transduction from OXTR and regulation of osteoblast activity.
BMP/SMAD — regulates osteogenic differentiation.
RANKL/RANK/OPG — controls the formation and activity of osteoclasts.
PGE2 — a local mediator involved in the regulation of bone remodeling.
Leptin and adiponectin — adipokines that link energy metabolism to the state of bone tissue.
AVP — a neuropeptide that has structural and functional similarity to oxytocin and is involved in the regulation of a number of physiological processes.
There is also a connection with Wnt, but it's not as clear-cut there.
OXYTOCIN AND CHONDROCYTES
OXTR is expressed in chondrocytes, and it can influence the expression of:
SOX9 — a key transcription factor of chondrogenic differentiation.
COMP — an extracellular matrix protein of cartilage.
SOX9 is especially important for the formation and maintenance of chondrocytes, primarily in the proliferative zone. It regulates the expression of a number of cartilage matrix genes: type 2 collagen and ACAN. The detection of an effect on SOX9 and COMP does not yet prove that oxytocin stimulates chondrocyte proliferation or hypertrophy. This is only a theory.
EFFECT OF OXYTOCIN ON BONE MINERAL DENSITY
Many studies have demonstrated a significant association between oxytocin and BMD, but not everything is so clear-cut. For example, in a study involving 1,097 postmenopausal women, higher oxytocin values were associated with BMD levels. In men aged 50+, no association was found between oxytocin and BMD. In men with diabetes insipidus, an association was found between oxytocin and BMD. There is an association, but it's not as clear-cut as one would like.
CONCLUSION
As it turns out, oxytocin is not just a hormone that affects mood and trust. It has a full-fledged effect on bone, as well as a theoretical effect on growth plates.

You mean @Mr. Oxytocin?
 

Skull

Head Moderator
Staff member
Joined
Mar 16, 2026
Posts
6,185
Reputation
27,458
Oxytocin is a peptide hormone that is synthesized primarily in the hypothalamus and released into the blood through the posterior pituitary gland. But it affects not only mental state, it also plays a significant role in bone metabolism.
In bone, it works through the OXTR receptor, which is located on osteoblasts and their precursors. Activation of these receptors can influence osteoblast differentiation and the activity of signaling pathways that affect bone mass.

EFFECTS ON OSTEOBLASTS AND BONE METABOLISM MARKERS
Oxytocin can stimulate osteogenic differentiation of cells.
BMP2 — a protein involved in the regulation of osteogenic differentiation.
RUNX2 — one of the key transcription factors required for osteoblast formation.
SP7 — a transcription factor required for further osteoblast differentiation.
ATF4 — a transcription factor involved in the functioning and maturation of osteoblasts.
ALP — a marker of osteoblastic activity associated with matrix mineralization.
OC — a protein involved in bone formation.
OPN and BSP — extracellular matrix proteins involved in mineralization and bone creation.
SHN2 and SHN3 — regulatory proteins involved in signal transduction and control of the expression of genes related to osteogenesis.
OT → OXTR → BMP-2 → SHN2/SHN3, SP7 and ATF4 → osteoblastic differentiation. RUNX2 is also among the regulators whose expression is increased by oxytocin.

Oxytocin stimulates the differentiation of osteoblasts into a mineralizing phenotype, which is accompanied by increased BMP2 expression. Then BMP2 acts on the intracellular BMP receptor system and the associated regulatory mechanisms. Key points:
BMPR1A, ALK3, BMPR1B, and ALK6 — type 1 BMP receptors.
BMPR2 — type 2 BMP receptor.
SMAD1, SMAD5, and SMAD9 — intracellular proteins responsible for signal transduction.
SMAD4 — a protein involved in forming the transcription complex..
Receptor activation leads to the phosphorylation of SMAD1/5/9, their interaction with SMAD4, and a subsequent effect on gene expression.
EFFECTS ON MESENCHYMAL STEM CELLS
Bone marrow mesenchymal stem cells are capable of differentiating into several cell types.
1. Osteoblasts
2. Chondrocytes
3. Adipocytes
Oxytocin can influence the direction of this differentiation by promoting osteogenesis and altering the balance between osteoblast and adipocyte formation. BMP2, RUNX2, SP7, and PPARG are involved in this. Increased activity of osteogenic factors and changes in adipogenic differentiation can shift the cellular balance toward bone tissue formation.
REGULATION OF BONE MATRIX MINERALIZATION
Oxytocin affects not only the differentiation of osteoblasts but also indicators of their functional activity. An increase in the expression of these markers has been observed:
ALP — alkaline phosphatase, involved in creating conditions for matrix mineralization.
BGLAP — the osteocalcin gene, a bone matrix protein.
SPP1 — the osteopontin gene, involved in the regulation of mineralization and cell-matrix interaction.
IBSP — the bone sialoprotein gene, involved in mineralization.
COL1A1 — the type 1 collagen gene, the main component of bone matrix.
These proteins ensure the formation of the extracellular matrix, as well as its subsequent mineralization. There is also a possible effect of oxytocin on the translocation of OXTR into the osteoblast nucleus and the regulation of their mineralizing activity.
EFFECTS ON OSTEOCLASTOGENESIS
Oxytocin also affects osteoclasts. The RANKL/RANK/OPG axis is involved here.
RANKL — a protein that binds to the RANK receptor and stimulates osteoclast differentiation.
RANK — a receptor located on osteoclasts.
OPG — a receptor that prevents RANKL from binding to RANK.
MCSF — a factor necessary for the survival and development of osteoclast precursors.
When RANKL binds to RANK, intracellular signaling is initiated involving TRAF6. After that, the following cascade is activated: RANKL -> RANK -> TRAF6 -> NF and MAPK -> cFOS -> NFATc1 -> osteoclastogenesis.
Oxytocin can increase RANKL and decrease OPG, thereby increasing the activity of osteoclast maturation. But the effect of oxytocin on mature osteoclasts differs from its effect on their precursors.
SUPPRESSION OF RESORPTIVE ACTIVITY OF MATURE OSTEOCLASTS
On one hand, it can stimulate the formation of osteoclasts, and on the other, it can suppress the resorptive activity of already mature osteoclasts. When OXTR is stimulated in mature osteoclasts, intracellular calcium increases. Unlike the short-term calcium signal produced by osteoblasts, in osteoclasts the calcium increase can be more prolonged. This promotes the formation of nitric oxide, which is involved in suppressing the functional activity of osteoclasts.
OT -> OXTR -> PLCB -> IP3 -> increase in intracellular calcium -> nitric oxide -> decrease in resorptive activity.
Oxytocin can suppress bone resorption by mature osteoclasts despite stimulating their formation. The number of osteoclasts ≠ the intensity of resorption.
ESTROGEN AND THE LOCAL OXYTOCIN/OXTR FEEDBACK LOOP
Estradiol can stimulate the synthesis of oxytocin by osteoblasts via MAPK/ERK, as well as influence OXTR expression. Ultimately, a local positive feedback loop is formed: estradiol -> MAPK/ERK -> increased oxytocin synthesis and OXTR expression -> enhanced oxytocin/OXTR signaling. Osteoblasts themselves are capable of synthesizing oxytocin, acting on their own receptors and on neighboring cells. Bone can use not only oxytocin coming from the bloodstream but also the local oxytocin system.
INTERACTION WITH OTHER SIGNALING PATHWAYS
MAPK/ERK — involved in signal transduction from OXTR and regulation of osteoblast activity.
BMP/SMAD — regulates osteogenic differentiation.
RANKL/RANK/OPG — controls the formation and activity of osteoclasts.
PGE2 — a local mediator involved in the regulation of bone remodeling.
Leptin and adiponectin — adipokines that link energy metabolism to the state of bone tissue.
AVP — a neuropeptide that has structural and functional similarity to oxytocin and is involved in the regulation of a number of physiological processes.
There is also a connection with Wnt, but it's not as clear-cut there.
OXYTOCIN AND CHONDROCYTES
OXTR is expressed in chondrocytes, and it can influence the expression of:
SOX9 — a key transcription factor of chondrogenic differentiation.
COMP — an extracellular matrix protein of cartilage.
SOX9 is especially important for the formation and maintenance of chondrocytes, primarily in the proliferative zone. It regulates the expression of a number of cartilage matrix genes: type 2 collagen and ACAN. The detection of an effect on SOX9 and COMP does not yet prove that oxytocin stimulates chondrocyte proliferation or hypertrophy. This is only a theory.
EFFECT OF OXYTOCIN ON BONE MINERAL DENSITY
Many studies have demonstrated a significant association between oxytocin and BMD, but not everything is so clear-cut. For example, in a study involving 1,097 postmenopausal women, higher oxytocin values were associated with BMD levels. In men aged 50+, no association was found between oxytocin and BMD. In men with diabetes insipidus, an association was found between oxytocin and BMD. There is an association, but it's not as clear-cut as one would like.
CONCLUSION
As it turns out, oxytocin is not just a hormone that affects mood and trust. It has a full-fledged effect on bone, as well as a theoretical effect on growth plates.

Nice work
 

Hexum.

.
Joined
Dec 13, 2025
Posts
3,839
Reputation
450
Oxytocin is a peptide hormone that is synthesized primarily in the hypothalamus and released into the blood through the posterior pituitary gland. But it affects not only mental state, it also plays a significant role in bone metabolism.
In bone, it works through the OXTR receptor, which is located on osteoblasts and their precursors. Activation of these receptors can influence osteoblast differentiation and the activity of signaling pathways that affect bone mass.

EFFECTS ON OSTEOBLASTS AND BONE METABOLISM MARKERS
Oxytocin can stimulate osteogenic differentiation of cells.
BMP2 — a protein involved in the regulation of osteogenic differentiation.
RUNX2 — one of the key transcription factors required for osteoblast formation.
SP7 — a transcription factor required for further osteoblast differentiation.
ATF4 — a transcription factor involved in the functioning and maturation of osteoblasts.
ALP — a marker of osteoblastic activity associated with matrix mineralization.
OC — a protein involved in bone formation.
OPN and BSP — extracellular matrix proteins involved in mineralization and bone creation.
SHN2 and SHN3 — regulatory proteins involved in signal transduction and control of the expression of genes related to osteogenesis.
OT → OXTR → BMP-2 → SHN2/SHN3, SP7 and ATF4 → osteoblastic differentiation. RUNX2 is also among the regulators whose expression is increased by oxytocin.

Oxytocin stimulates the differentiation of osteoblasts into a mineralizing phenotype, which is accompanied by increased BMP2 expression. Then BMP2 acts on the intracellular BMP receptor system and the associated regulatory mechanisms. Key points:
BMPR1A, ALK3, BMPR1B, and ALK6 — type 1 BMP receptors.
BMPR2 — type 2 BMP receptor.
SMAD1, SMAD5, and SMAD9 — intracellular proteins responsible for signal transduction.
SMAD4 — a protein involved in forming the transcription complex..
Receptor activation leads to the phosphorylation of SMAD1/5/9, their interaction with SMAD4, and a subsequent effect on gene expression.
EFFECTS ON MESENCHYMAL STEM CELLS
Bone marrow mesenchymal stem cells are capable of differentiating into several cell types.
1. Osteoblasts
2. Chondrocytes
3. Adipocytes
Oxytocin can influence the direction of this differentiation by promoting osteogenesis and altering the balance between osteoblast and adipocyte formation. BMP2, RUNX2, SP7, and PPARG are involved in this. Increased activity of osteogenic factors and changes in adipogenic differentiation can shift the cellular balance toward bone tissue formation.
REGULATION OF BONE MATRIX MINERALIZATION
Oxytocin affects not only the differentiation of osteoblasts but also indicators of their functional activity. An increase in the expression of these markers has been observed:
ALP — alkaline phosphatase, involved in creating conditions for matrix mineralization.
BGLAP — the osteocalcin gene, a bone matrix protein.
SPP1 — the osteopontin gene, involved in the regulation of mineralization and cell-matrix interaction.
IBSP — the bone sialoprotein gene, involved in mineralization.
COL1A1 — the type 1 collagen gene, the main component of bone matrix.
These proteins ensure the formation of the extracellular matrix, as well as its subsequent mineralization. There is also a possible effect of oxytocin on the translocation of OXTR into the osteoblast nucleus and the regulation of their mineralizing activity.
EFFECTS ON OSTEOCLASTOGENESIS
Oxytocin also affects osteoclasts. The RANKL/RANK/OPG axis is involved here.
RANKL — a protein that binds to the RANK receptor and stimulates osteoclast differentiation.
RANK — a receptor located on osteoclasts.
OPG — a receptor that prevents RANKL from binding to RANK.
MCSF — a factor necessary for the survival and development of osteoclast precursors.
When RANKL binds to RANK, intracellular signaling is initiated involving TRAF6. After that, the following cascade is activated: RANKL -> RANK -> TRAF6 -> NF and MAPK -> cFOS -> NFATc1 -> osteoclastogenesis.
Oxytocin can increase RANKL and decrease OPG, thereby increasing the activity of osteoclast maturation. But the effect of oxytocin on mature osteoclasts differs from its effect on their precursors.
SUPPRESSION OF RESORPTIVE ACTIVITY OF MATURE OSTEOCLASTS
On one hand, it can stimulate the formation of osteoclasts, and on the other, it can suppress the resorptive activity of already mature osteoclasts. When OXTR is stimulated in mature osteoclasts, intracellular calcium increases. Unlike the short-term calcium signal produced by osteoblasts, in osteoclasts the calcium increase can be more prolonged. This promotes the formation of nitric oxide, which is involved in suppressing the functional activity of osteoclasts.
OT -> OXTR -> PLCB -> IP3 -> increase in intracellular calcium -> nitric oxide -> decrease in resorptive activity.
Oxytocin can suppress bone resorption by mature osteoclasts despite stimulating their formation. The number of osteoclasts ≠ the intensity of resorption.
ESTROGEN AND THE LOCAL OXYTOCIN/OXTR FEEDBACK LOOP
Estradiol can stimulate the synthesis of oxytocin by osteoblasts via MAPK/ERK, as well as influence OXTR expression. Ultimately, a local positive feedback loop is formed: estradiol -> MAPK/ERK -> increased oxytocin synthesis and OXTR expression -> enhanced oxytocin/OXTR signaling. Osteoblasts themselves are capable of synthesizing oxytocin, acting on their own receptors and on neighboring cells. Bone can use not only oxytocin coming from the bloodstream but also the local oxytocin system.
INTERACTION WITH OTHER SIGNALING PATHWAYS
MAPK/ERK — involved in signal transduction from OXTR and regulation of osteoblast activity.
BMP/SMAD — regulates osteogenic differentiation.
RANKL/RANK/OPG — controls the formation and activity of osteoclasts.
PGE2 — a local mediator involved in the regulation of bone remodeling.
Leptin and adiponectin — adipokines that link energy metabolism to the state of bone tissue.
AVP — a neuropeptide that has structural and functional similarity to oxytocin and is involved in the regulation of a number of physiological processes.
There is also a connection with Wnt, but it's not as clear-cut there.
OXYTOCIN AND CHONDROCYTES
OXTR is expressed in chondrocytes, and it can influence the expression of:
SOX9 — a key transcription factor of chondrogenic differentiation.
COMP — an extracellular matrix protein of cartilage.
SOX9 is especially important for the formation and maintenance of chondrocytes, primarily in the proliferative zone. It regulates the expression of a number of cartilage matrix genes: type 2 collagen and ACAN. The detection of an effect on SOX9 and COMP does not yet prove that oxytocin stimulates chondrocyte proliferation or hypertrophy. This is only a theory.
EFFECT OF OXYTOCIN ON BONE MINERAL DENSITY
Many studies have demonstrated a significant association between oxytocin and BMD, but not everything is so clear-cut. For example, in a study involving 1,097 postmenopausal women, higher oxytocin values were associated with BMD levels. In men aged 50+, no association was found between oxytocin and BMD. In men with diabetes insipidus, an association was found between oxytocin and BMD. There is an association, but it's not as clear-cut as one would like.
CONCLUSION
As it turns out, oxytocin is not just a hormone that affects mood and trust. It has a full-fledged effect on bone, as well as a theoretical effect on growth plates.

im actually mirin i read the whole thing now good job
 
Joined
Feb 25, 2026
Posts
3,492
Reputation
4,287
Oxytocin is a peptide hormone that is synthesized primarily in the hypothalamus and released into the blood through the posterior pituitary gland. But it affects not only mental state, it also plays a significant role in bone metabolism.
In bone, it works through the OXTR receptor, which is located on osteoblasts and their precursors. Activation of these receptors can influence osteoblast differentiation and the activity of signaling pathways that affect bone mass.

EFFECTS ON OSTEOBLASTS AND BONE METABOLISM MARKERS
Oxytocin can stimulate osteogenic differentiation of cells.
BMP2 — a protein involved in the regulation of osteogenic differentiation.
RUNX2 — one of the key transcription factors required for osteoblast formation.
SP7 — a transcription factor required for further osteoblast differentiation.
ATF4 — a transcription factor involved in the functioning and maturation of osteoblasts.
ALP — a marker of osteoblastic activity associated with matrix mineralization.
OC — a protein involved in bone formation.
OPN and BSP — extracellular matrix proteins involved in mineralization and bone creation.
SHN2 and SHN3 — regulatory proteins involved in signal transduction and control of the expression of genes related to osteogenesis.
OT → OXTR → BMP-2 → SHN2/SHN3, SP7 and ATF4 → osteoblastic differentiation. RUNX2 is also among the regulators whose expression is increased by oxytocin.

Oxytocin stimulates the differentiation of osteoblasts into a mineralizing phenotype, which is accompanied by increased BMP2 expression. Then BMP2 acts on the intracellular BMP receptor system and the associated regulatory mechanisms. Key points:
BMPR1A, ALK3, BMPR1B, and ALK6 — type 1 BMP receptors.
BMPR2 — type 2 BMP receptor.
SMAD1, SMAD5, and SMAD9 — intracellular proteins responsible for signal transduction.
SMAD4 — a protein involved in forming the transcription complex..
Receptor activation leads to the phosphorylation of SMAD1/5/9, their interaction with SMAD4, and a subsequent effect on gene expression.
EFFECTS ON MESENCHYMAL STEM CELLS
Bone marrow mesenchymal stem cells are capable of differentiating into several cell types.
1. Osteoblasts
2. Chondrocytes
3. Adipocytes
Oxytocin can influence the direction of this differentiation by promoting osteogenesis and altering the balance between osteoblast and adipocyte formation. BMP2, RUNX2, SP7, and PPARG are involved in this. Increased activity of osteogenic factors and changes in adipogenic differentiation can shift the cellular balance toward bone tissue formation.
REGULATION OF BONE MATRIX MINERALIZATION
Oxytocin affects not only the differentiation of osteoblasts but also indicators of their functional activity. An increase in the expression of these markers has been observed:
ALP — alkaline phosphatase, involved in creating conditions for matrix mineralization.
BGLAP — the osteocalcin gene, a bone matrix protein.
SPP1 — the osteopontin gene, involved in the regulation of mineralization and cell-matrix interaction.
IBSP — the bone sialoprotein gene, involved in mineralization.
COL1A1 — the type 1 collagen gene, the main component of bone matrix.
These proteins ensure the formation of the extracellular matrix, as well as its subsequent mineralization. There is also a possible effect of oxytocin on the translocation of OXTR into the osteoblast nucleus and the regulation of their mineralizing activity.
EFFECTS ON OSTEOCLASTOGENESIS
Oxytocin also affects osteoclasts. The RANKL/RANK/OPG axis is involved here.
RANKL — a protein that binds to the RANK receptor and stimulates osteoclast differentiation.
RANK — a receptor located on osteoclasts.
OPG — a receptor that prevents RANKL from binding to RANK.
MCSF — a factor necessary for the survival and development of osteoclast precursors.
When RANKL binds to RANK, intracellular signaling is initiated involving TRAF6. After that, the following cascade is activated: RANKL -> RANK -> TRAF6 -> NF and MAPK -> cFOS -> NFATc1 -> osteoclastogenesis.
Oxytocin can increase RANKL and decrease OPG, thereby increasing the activity of osteoclast maturation. But the effect of oxytocin on mature osteoclasts differs from its effect on their precursors.
SUPPRESSION OF RESORPTIVE ACTIVITY OF MATURE OSTEOCLASTS
On one hand, it can stimulate the formation of osteoclasts, and on the other, it can suppress the resorptive activity of already mature osteoclasts. When OXTR is stimulated in mature osteoclasts, intracellular calcium increases. Unlike the short-term calcium signal produced by osteoblasts, in osteoclasts the calcium increase can be more prolonged. This promotes the formation of nitric oxide, which is involved in suppressing the functional activity of osteoclasts.
OT -> OXTR -> PLCB -> IP3 -> increase in intracellular calcium -> nitric oxide -> decrease in resorptive activity.
Oxytocin can suppress bone resorption by mature osteoclasts despite stimulating their formation. The number of osteoclasts ≠ the intensity of resorption.
ESTROGEN AND THE LOCAL OXYTOCIN/OXTR FEEDBACK LOOP
Estradiol can stimulate the synthesis of oxytocin by osteoblasts via MAPK/ERK, as well as influence OXTR expression. Ultimately, a local positive feedback loop is formed: estradiol -> MAPK/ERK -> increased oxytocin synthesis and OXTR expression -> enhanced oxytocin/OXTR signaling. Osteoblasts themselves are capable of synthesizing oxytocin, acting on their own receptors and on neighboring cells. Bone can use not only oxytocin coming from the bloodstream but also the local oxytocin system.
INTERACTION WITH OTHER SIGNALING PATHWAYS
MAPK/ERK — involved in signal transduction from OXTR and regulation of osteoblast activity.
BMP/SMAD — regulates osteogenic differentiation.
RANKL/RANK/OPG — controls the formation and activity of osteoclasts.
PGE2 — a local mediator involved in the regulation of bone remodeling.
Leptin and adiponectin — adipokines that link energy metabolism to the state of bone tissue.
AVP — a neuropeptide that has structural and functional similarity to oxytocin and is involved in the regulation of a number of physiological processes.
There is also a connection with Wnt, but it's not as clear-cut there.
OXYTOCIN AND CHONDROCYTES
OXTR is expressed in chondrocytes, and it can influence the expression of:
SOX9 — a key transcription factor of chondrogenic differentiation.
COMP — an extracellular matrix protein of cartilage.
SOX9 is especially important for the formation and maintenance of chondrocytes, primarily in the proliferative zone. It regulates the expression of a number of cartilage matrix genes: type 2 collagen and ACAN. The detection of an effect on SOX9 and COMP does not yet prove that oxytocin stimulates chondrocyte proliferation or hypertrophy. This is only a theory.
EFFECT OF OXYTOCIN ON BONE MINERAL DENSITY
Many studies have demonstrated a significant association between oxytocin and BMD, but not everything is so clear-cut. For example, in a study involving 1,097 postmenopausal women, higher oxytocin values were associated with BMD levels. In men aged 50+, no association was found between oxytocin and BMD. In men with diabetes insipidus, an association was found between oxytocin and BMD. There is an association, but it's not as clear-cut as one would like.
CONCLUSION
As it turns out, oxytocin is not just a hormone that affects mood and trust. It has a full-fledged effect on bone, as well as a theoretical effect on growth plates.

Half water, half good info

Good job
 

DECADYLAN

Iron
Joined
Nov 17, 2026
Posts
12
Reputation
9
Oxytocin is a peptide hormone that is synthesized primarily in the hypothalamus and released into the blood through the posterior pituitary gland. But it affects not only mental state, it also plays a significant role in bone metabolism.
In bone, it works through the OXTR receptor, which is located on osteoblasts and their precursors. Activation of these receptors can influence osteoblast differentiation and the activity of signaling pathways that affect bone mass.

EFFECTS ON OSTEOBLASTS AND BONE METABOLISM MARKERS
Oxytocin can stimulate osteogenic differentiation of cells.
BMP2 — a protein involved in the regulation of osteogenic differentiation.
RUNX2 — one of the key transcription factors required for osteoblast formation.
SP7 — a transcription factor required for further osteoblast differentiation.
ATF4 — a transcription factor involved in the functioning and maturation of osteoblasts.
ALP — a marker of osteoblastic activity associated with matrix mineralization.
OC — a protein involved in bone formation.
OPN and BSP — extracellular matrix proteins involved in mineralization and bone creation.
SHN2 and SHN3 — regulatory proteins involved in signal transduction and control of the expression of genes related to osteogenesis.
OT → OXTR → BMP-2 → SHN2/SHN3, SP7 and ATF4 → osteoblastic differentiation. RUNX2 is also among the regulators whose expression is increased by oxytocin.

Oxytocin stimulates the differentiation of osteoblasts into a mineralizing phenotype, which is accompanied by increased BMP2 expression. Then BMP2 acts on the intracellular BMP receptor system and the associated regulatory mechanisms. Key points:
BMPR1A, ALK3, BMPR1B, and ALK6 — type 1 BMP receptors.
BMPR2 — type 2 BMP receptor.
SMAD1, SMAD5, and SMAD9 — intracellular proteins responsible for signal transduction.
SMAD4 — a protein involved in forming the transcription complex..
Receptor activation leads to the phosphorylation of SMAD1/5/9, their interaction with SMAD4, and a subsequent effect on gene expression.
EFFECTS ON MESENCHYMAL STEM CELLS
Bone marrow mesenchymal stem cells are capable of differentiating into several cell types.
1. Osteoblasts
2. Chondrocytes
3. Adipocytes
Oxytocin can influence the direction of this differentiation by promoting osteogenesis and altering the balance between osteoblast and adipocyte formation. BMP2, RUNX2, SP7, and PPARG are involved in this. Increased activity of osteogenic factors and changes in adipogenic differentiation can shift the cellular balance toward bone tissue formation.
REGULATION OF BONE MATRIX MINERALIZATION
Oxytocin affects not only the differentiation of osteoblasts but also indicators of their functional activity. An increase in the expression of these markers has been observed:
ALP — alkaline phosphatase, involved in creating conditions for matrix mineralization.
BGLAP — the osteocalcin gene, a bone matrix protein.
SPP1 — the osteopontin gene, involved in the regulation of mineralization and cell-matrix interaction.
IBSP — the bone sialoprotein gene, involved in mineralization.
COL1A1 — the type 1 collagen gene, the main component of bone matrix.
These proteins ensure the formation of the extracellular matrix, as well as its subsequent mineralization. There is also a possible effect of oxytocin on the translocation of OXTR into the osteoblast nucleus and the regulation of their mineralizing activity.
EFFECTS ON OSTEOCLASTOGENESIS
Oxytocin also affects osteoclasts. The RANKL/RANK/OPG axis is involved here.
RANKL — a protein that binds to the RANK receptor and stimulates osteoclast differentiation.
RANK — a receptor located on osteoclasts.
OPG — a receptor that prevents RANKL from binding to RANK.
MCSF — a factor necessary for the survival and development of osteoclast precursors.
When RANKL binds to RANK, intracellular signaling is initiated involving TRAF6. After that, the following cascade is activated: RANKL -> RANK -> TRAF6 -> NF and MAPK -> cFOS -> NFATc1 -> osteoclastogenesis.
Oxytocin can increase RANKL and decrease OPG, thereby increasing the activity of osteoclast maturation. But the effect of oxytocin on mature osteoclasts differs from its effect on their precursors.
SUPPRESSION OF RESORPTIVE ACTIVITY OF MATURE OSTEOCLASTS
On one hand, it can stimulate the formation of osteoclasts, and on the other, it can suppress the resorptive activity of already mature osteoclasts. When OXTR is stimulated in mature osteoclasts, intracellular calcium increases. Unlike the short-term calcium signal produced by osteoblasts, in osteoclasts the calcium increase can be more prolonged. This promotes the formation of nitric oxide, which is involved in suppressing the functional activity of osteoclasts.
OT -> OXTR -> PLCB -> IP3 -> increase in intracellular calcium -> nitric oxide -> decrease in resorptive activity.
Oxytocin can suppress bone resorption by mature osteoclasts despite stimulating their formation. The number of osteoclasts ≠ the intensity of resorption.
ESTROGEN AND THE LOCAL OXYTOCIN/OXTR FEEDBACK LOOP
Estradiol can stimulate the synthesis of oxytocin by osteoblasts via MAPK/ERK, as well as influence OXTR expression. Ultimately, a local positive feedback loop is formed: estradiol -> MAPK/ERK -> increased oxytocin synthesis and OXTR expression -> enhanced oxytocin/OXTR signaling. Osteoblasts themselves are capable of synthesizing oxytocin, acting on their own receptors and on neighboring cells. Bone can use not only oxytocin coming from the bloodstream but also the local oxytocin system.
INTERACTION WITH OTHER SIGNALING PATHWAYS
MAPK/ERK — involved in signal transduction from OXTR and regulation of osteoblast activity.
BMP/SMAD — regulates osteogenic differentiation.
RANKL/RANK/OPG — controls the formation and activity of osteoclasts.
PGE2 — a local mediator involved in the regulation of bone remodeling.
Leptin and adiponectin — adipokines that link energy metabolism to the state of bone tissue.
AVP — a neuropeptide that has structural and functional similarity to oxytocin and is involved in the regulation of a number of physiological processes.
There is also a connection with Wnt, but it's not as clear-cut there.
OXYTOCIN AND CHONDROCYTES
OXTR is expressed in chondrocytes, and it can influence the expression of:
SOX9 — a key transcription factor of chondrogenic differentiation.
COMP — an extracellular matrix protein of cartilage.
SOX9 is especially important for the formation and maintenance of chondrocytes, primarily in the proliferative zone. It regulates the expression of a number of cartilage matrix genes: type 2 collagen and ACAN. The detection of an effect on SOX9 and COMP does not yet prove that oxytocin stimulates chondrocyte proliferation or hypertrophy. This is only a theory.
EFFECT OF OXYTOCIN ON BONE MINERAL DENSITY
Many studies have demonstrated a significant association between oxytocin and BMD, but not everything is so clear-cut. For example, in a study involving 1,097 postmenopausal women, higher oxytocin values were associated with BMD levels. In men aged 50+, no association was found between oxytocin and BMD. In men with diabetes insipidus, an association was found between oxytocin and BMD. There is an association, but it's not as clear-cut as one would like.
CONCLUSION
As it turns out, oxytocin is not just a hormone that affects mood and trust. It has a full-fledged effect on bone, as well as a theoretical effect on growth plates.

Just talk to girls instead
 
Joined
Nov 20, 2026
Posts
7
Reputation
8
Oxytocin is a peptide hormone that is synthesized primarily in the hypothalamus and released into the blood through the posterior pituitary gland. But it affects not only mental state, it also plays a significant role in bone metabolism.
In bone, it works through the OXTR receptor, which is located on osteoblasts and their precursors. Activation of these receptors can influence osteoblast differentiation and the activity of signaling pathways that affect bone mass.

EFFECTS ON OSTEOBLASTS AND BONE METABOLISM MARKERS
Oxytocin can stimulate osteogenic differentiation of cells.
BMP2 — a protein involved in the regulation of osteogenic differentiation.
RUNX2 — one of the key transcription factors required for osteoblast formation.
SP7 — a transcription factor required for further osteoblast differentiation.
ATF4 — a transcription factor involved in the functioning and maturation of osteoblasts.
ALP — a marker of osteoblastic activity associated with matrix mineralization.
OC — a protein involved in bone formation.
OPN and BSP — extracellular matrix proteins involved in mineralization and bone creation.
SHN2 and SHN3 — regulatory proteins involved in signal transduction and control of the expression of genes related to osteogenesis.
OT → OXTR → BMP-2 → SHN2/SHN3, SP7 and ATF4 → osteoblastic differentiation. RUNX2 is also among the regulators whose expression is increased by oxytocin.

Oxytocin stimulates the differentiation of osteoblasts into a mineralizing phenotype, which is accompanied by increased BMP2 expression. Then BMP2 acts on the intracellular BMP receptor system and the associated regulatory mechanisms. Key points:
BMPR1A, ALK3, BMPR1B, and ALK6 — type 1 BMP receptors.
BMPR2 — type 2 BMP receptor.
SMAD1, SMAD5, and SMAD9 — intracellular proteins responsible for signal transduction.
SMAD4 — a protein involved in forming the transcription complex..
Receptor activation leads to the phosphorylation of SMAD1/5/9, their interaction with SMAD4, and a subsequent effect on gene expression.
EFFECTS ON MESENCHYMAL STEM CELLS
Bone marrow mesenchymal stem cells are capable of differentiating into several cell types.
1. Osteoblasts
2. Chondrocytes
3. Adipocytes
Oxytocin can influence the direction of this differentiation by promoting osteogenesis and altering the balance between osteoblast and adipocyte formation. BMP2, RUNX2, SP7, and PPARG are involved in this. Increased activity of osteogenic factors and changes in adipogenic differentiation can shift the cellular balance toward bone tissue formation.
REGULATION OF BONE MATRIX MINERALIZATION
Oxytocin affects not only the differentiation of osteoblasts but also indicators of their functional activity. An increase in the expression of these markers has been observed:
ALP — alkaline phosphatase, involved in creating conditions for matrix mineralization.
BGLAP — the osteocalcin gene, a bone matrix protein.
SPP1 — the osteopontin gene, involved in the regulation of mineralization and cell-matrix interaction.
IBSP — the bone sialoprotein gene, involved in mineralization.
COL1A1 — the type 1 collagen gene, the main component of bone matrix.
These proteins ensure the formation of the extracellular matrix, as well as its subsequent mineralization. There is also a possible effect of oxytocin on the translocation of OXTR into the osteoblast nucleus and the regulation of their mineralizing activity.
EFFECTS ON OSTEOCLASTOGENESIS
Oxytocin also affects osteoclasts. The RANKL/RANK/OPG axis is involved here.
RANKL — a protein that binds to the RANK receptor and stimulates osteoclast differentiation.
RANK — a receptor located on osteoclasts.
OPG — a receptor that prevents RANKL from binding to RANK.
MCSF — a factor necessary for the survival and development of osteoclast precursors.
When RANKL binds to RANK, intracellular signaling is initiated involving TRAF6. After that, the following cascade is activated: RANKL -> RANK -> TRAF6 -> NF and MAPK -> cFOS -> NFATc1 -> osteoclastogenesis.
Oxytocin can increase RANKL and decrease OPG, thereby increasing the activity of osteoclast maturation. But the effect of oxytocin on mature osteoclasts differs from its effect on their precursors.
SUPPRESSION OF RESORPTIVE ACTIVITY OF MATURE OSTEOCLASTS
On one hand, it can stimulate the formation of osteoclasts, and on the other, it can suppress the resorptive activity of already mature osteoclasts. When OXTR is stimulated in mature osteoclasts, intracellular calcium increases. Unlike the short-term calcium signal produced by osteoblasts, in osteoclasts the calcium increase can be more prolonged. This promotes the formation of nitric oxide, which is involved in suppressing the functional activity of osteoclasts.
OT -> OXTR -> PLCB -> IP3 -> increase in intracellular calcium -> nitric oxide -> decrease in resorptive activity.
Oxytocin can suppress bone resorption by mature osteoclasts despite stimulating their formation. The number of osteoclasts ≠ the intensity of resorption.
ESTROGEN AND THE LOCAL OXYTOCIN/OXTR FEEDBACK LOOP
Estradiol can stimulate the synthesis of oxytocin by osteoblasts via MAPK/ERK, as well as influence OXTR expression. Ultimately, a local positive feedback loop is formed: estradiol -> MAPK/ERK -> increased oxytocin synthesis and OXTR expression -> enhanced oxytocin/OXTR signaling. Osteoblasts themselves are capable of synthesizing oxytocin, acting on their own receptors and on neighboring cells. Bone can use not only oxytocin coming from the bloodstream but also the local oxytocin system.
INTERACTION WITH OTHER SIGNALING PATHWAYS
MAPK/ERK — involved in signal transduction from OXTR and regulation of osteoblast activity.
BMP/SMAD — regulates osteogenic differentiation.
RANKL/RANK/OPG — controls the formation and activity of osteoclasts.
PGE2 — a local mediator involved in the regulation of bone remodeling.
Leptin and adiponectin — adipokines that link energy metabolism to the state of bone tissue.
AVP — a neuropeptide that has structural and functional similarity to oxytocin and is involved in the regulation of a number of physiological processes.
There is also a connection with Wnt, but it's not as clear-cut there.
OXYTOCIN AND CHONDROCYTES
OXTR is expressed in chondrocytes, and it can influence the expression of:
SOX9 — a key transcription factor of chondrogenic differentiation.
COMP — an extracellular matrix protein of cartilage.
SOX9 is especially important for the formation and maintenance of chondrocytes, primarily in the proliferative zone. It regulates the expression of a number of cartilage matrix genes: type 2 collagen and ACAN. The detection of an effect on SOX9 and COMP does not yet prove that oxytocin stimulates chondrocyte proliferation or hypertrophy. This is only a theory.
EFFECT OF OXYTOCIN ON BONE MINERAL DENSITY
Many studies have demonstrated a significant association between oxytocin and BMD, but not everything is so clear-cut. For example, in a study involving 1,097 postmenopausal women, higher oxytocin values were associated with BMD levels. In men aged 50+, no association was found between oxytocin and BMD. In men with diabetes insipidus, an association was found between oxytocin and BMD. There is an association, but it's not as clear-cut as one would like.
CONCLUSION
As it turns out, oxytocin is not just a hormone that affects mood and trust. It has a full-fledged effect on bone, as well as a theoretical effect on growth plates.

Love this thread, mirin read all
 

Users who are viewing this thread

Contact us

Questions about your account or the forum? Email us. To report a post, use the Report button on it.

Open email app
shape1
shape2
shape3
shape4
shape5
shape6
Back
Top
Style